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R1037Growth Regulation: A Beginning
for the Hippo Pathway
A signaling pathway involving two protein kinases, Hippo and Warts,
restricts the growth of imaginal discs in Drosophila. Four recent studies
taken together show that the protocadherin Fat can regulateWarts in two
different ways.Iswar K. Hariharan
Genetic studies in Drosophila have
led to the identification of
a signaling pathway, sometimes
referred to as ‘the Hippo pathway’,
that appears to be important in
regulating tissue growth (reviewed
in [1,2]). Inactivating mutations in
several components of this
pathway result in a dramatic
overgrowth of mutant tissue in the
imaginal discs — sacs of epithelial
tissue found in the larva that
eventually become adult structures
such as the eye, wing and leg. Each
component of the Hippo pathway
identified to date has one or more
mammalian orthologs that
probably function in an analogous
manner to their Drosophila
counterparts. Thus, this pathway is
likely to have a role in diverse
species in the determination of the
overall size of individual organs.
Evidence is also accumulating to
show that altered signaling via this
pathway can contribute to the
development of cancer in
mammals [2–4].
At the core of this pathway
(reviewed in [1,2]), is a module
composed of two protein kinases,
Hippo and Warts. Hippo,
amember of the Ste20 superfamily,
acts upstream of Warts, a member
of the nuclear Dbf2 related (NDR)
family of protein kinases, and
activates it by directphosphorylation. Hippo-mediated
Warts activation is facilitated by
Salvador, aWWdomain-containing
protein that probably functions as
a scaffold, and also by Mats,
a protein that binds directly to
Warts. When activated, Warts can
phosphorylate a transcriptional
co-activator, Yorkie [5] and reduce
its activity, possibly by excluding it
from the nucleus. Yorkie promotes,
either directly or indirectly, the
transcription of genes that promote
growth and cell-cycle progression
as well as genes that inhibit
apoptosis. Thus, increased activity
of Hippo and Warts correlates with
a reduction in tissue growth and
a reduction of Hippo/Warts activity
allows growth to occur.
Given the obvious importance of
the Hippo pathway in regulating
tissue growth, a gaping hole in our
understanding of its role in
organismal development has been
the inability to correlate the level
of activation of this pathway
with any known physiological
parameter. In contrast, the
activity of many other growth
regulators can be stimulated by
extracellular growth factors (e.g.
phosphatidylinositol 3-kinase) or
the availability of nutrients (e.g.
Tor). A possible role for the Hippo
pathway was suggested by the
finding that two proteins with four
point one, ezrin, radixin, moesin
(FERM) domains, Merlin andExpanded, may function
redundantly as activators of Hippo
[6]. Proteins with FERM domains
are thought to link the cortical
cytoskeleton with integral
membrane proteins [7], leading to
speculation that they, and hence
the Hippo pathway, may function
to inhibit tissue growth in response
to increased cell density or
possibly even mechanical
stresses.
Four recent studies [8–11], three
published in Current Biology and
one in Nature Genetics all implicate
the protocadherin Fat [12,13] as an
activator of the Hippo pathway.
Linking Fat to the Hippo pathway
represents an important
development, since it is the first
evidence that the activity of the
Hippo pathway can potentially be
regulated by an extracellular signal
that is most likely a ligand
expressed on the surface of an
adjacent cell. While it has been
known for many years that
inactivating mutations in fat result
in increased tissue growth, the
reason for the increase in growth
was not known. By analyzing the
expression of transcriptional
targets of the Hippo pathway, the
authors of all four studies conclude
that cells that are mutant for fat
resemble, in several ways, cells
that have inactivating mutations in
hippo or warts. Importantly,
however, the studies differ in their
explanations for how Fat can
regulate signaling via the Hippo
pathway and propose two distinct
models of Fat function. As will be
discussed below, it is likely that Fat
can regulate the Hippo pathway in
both of these ways, but their
relative importance under
physiological conditions has yet to
be determined.


















Figure 1. Two models for the regulation of Warts by Fat. The components of the path-
way that restrict growth, Fat (Ft), Expanded (Ex), Merlin (Mer), Hippo (Hpo), Salvador
(Sav), Mats and Warts (Wts) are shown in red. The components that promote growth,
Dachs (D) and Yorkie (Yki) are shown in green.Three of the four studies [8–10]
order Fat, Expanded, Hippo and
Warts in a linear pathway (Figure 1,
Model 1). The evidence for this
model comes from the following
observations. First, the localization
of Expanded to the apical surface
of the cells, and possibly its
stability, are reduced in fat mutant
cells. Second, overexpression of
an activated form of Fat can induce
Hippo phosphorylation (an
indicator of active Hippo) as well as
Warts phosphorylation. Third,
using a transcriptional assay of
Yorkie activity in cell culture, it was
shown that the ability of Fat to
inhibit Yorkie activity was reduced
by knockdown of hippo orwarts via
RNA interference. Finally, genetic
epistasis experiments show that
activation of the pathway at the
level of expanded or hippo can
mostly bypass the requirement for
fat. Interestingly, there appears to
be no evidence that Merlin, the
other FERM-domain containing
protein in the pathway, functions
downstream of Fat suggesting that
Merlin may receive inputs from
other upstream signals.
The fourth study [11] proposes
that Fat promotes Warts-mediated
signaling by regulating the
abundance of the Warts protein via
an unconventional myosin Dachs
[14] (Figure 1, Model 2). In thismodel, the path from Fat to Warts
bypasses Expanded and Hippo.
Three lines of evidence are
presented to support this
conclusion. First, the analysis of
double-mutant combinations
places fat upstream of dachs and
dachs upstream of both hippo and
warts. In other words, when both
fat and dachs are inactivated, the
observed phenotypes are more
similar to dachs mutants than fat
mutants. In contrast, when dachs is
inactivated together with either
expanded or warts, the phenotype
is more similar to single mutants of
expanded or warts. Second, the
levels of Warts protein, but not
the levels of Hippo, Salvador,
Merlin or Mats are reduced in fat
mutant tissue. Third, when
overexpressed in tissue culture
cells, Dachs can bind to Warts. The
authors therefore suggest that
Fat regulates the abundance of
Warts via Dachs, while Hippo
independently regulates the
enzymatic activity of Warts. In this
view, Warts is the point of
convergence of two distinct
upstream signals.
So far, none of the experiments
described in support of one model
completely excludes the other.
Indeed, many of the experimental
results are consistent with Fat
being able to regulate Wartsactivity in at least two different
ways and also with Warts being
regulated by signals that are
independent of Fat. The
observation that the phenotype of
fat expanded double mutants is
a little more severe than that of
expanded mutants suggests that
Fat can regulate Warts
independently of Expanded. Also
consistent with this conclusion are
the results that show that the
suppression of fat mutant
phenotypes by the overexpression
of Hippo pathway components is
typically incomplete. In addition,
the observation of reduced growth
and decreased transcription of
Yorkie targets in cells doubly
mutant for fat and dachs would
seem to suggest that the elevated
levels of Warts in these cells can
still be activated by a pathway that





two furtherdevelopments. First, the
precise biochemical mechanisms
by which Fat regulatesWarts levels
and Hippo activity need to be
defined. At present, the exact
functional consequence of either
the abnormal Expanded
localization in fat clones or the
binding of Dachs to Warts is not
known. Second, methods for
quantifying the activity of different
pathway components under
normal physiological conditions
need to be devised.
Much of what we know about the
function of Fat as a receptor comes
from studies on its role in the
regulation of planar cell polarity
(PCP) in both the wing and the eye
[15]. In cells of the eye imaginal disc
Fat regulates the chirality of the
arrangement of clusters of
developing photoreceptor cells by
directing a position-dependent
cell-fate decision. Central to this
process is the breaking of
symmetry in the precursors of the
R3 and R4 photoreceptor cells by
the establishment of different
levels of Frizzled activity in those
two cells as a consequence of
a difference in their levels of Fat
activity. The difference in Fat
activity probably results from
graded expression of another
protocadherin, Dachsous [16],
Left–Right Asymmetry: Making the
Right Decision Early
A left–right asymmetry in neuronal function is specified surprisingly early
during embryogenesis in Caenorhabditis elegans. Do early cues
influence left–right asymmetries in other animals? How are early cues
remembered until late in development?
Bruce Bowerman
The bodies of most animals exhibit
extensive left–right symmetry.
However, there are numerous
exceptions [1], and these left–right
asymmetries capture our
attention. When and how during
development are they specified?
What are their functions? In
a recent issue of Current Biology,
Poole and Hobert [2] describe an
informative analysis of a case of
left–right asymmetry, or laterality,
Dispatch
R1039which is thought to be a ligand for
Fat. The cell that is closer to the
equator has higher levels of Fat
activity and adopts the R3 cell fate.
Based on the phenotype of
dachsous mutants, it is likely that
a ligand other than Dachsous is
important for the ability of Fat to
activate Warts and inhibit Yorkie
function. Different effector
pathways downstream of Fat
appear to function in growth
regulation and planar cell polarity
[14]. For instance, while Fat
regulates non-canonical Frizzled
signaling during PCP
determination, Frizzled has no
obvious function in growth control.
It is conceivable that the interaction
of Fat with different ligands
somehow selectively activates
different downstream pathways.
What can the role of Fat in PCP
tell us about its function in
regulating imaginal disc growth? In
establishing planar cell polarity,
cells determine their direction of
polarization after comparing the
levels of some parameter (e.g.
Frizzled activity) with their
immediate neighbors [17]. A similar
mechanism can be invoked to
explain the regulation of organ size
[18,19]. When a morphogen (e.g.
Dpp) is produced at one boundary
of a compartment and drops to
a level close to zero at the opposite
boundary, the gradient of
morphogen concentration is
initially very steep. As growth
occurs, the same drop in
morphogen concentration occurs
over a distance of many more cell
diameters resulting in a decrease in
the slope of the gradient. The
cessation of organ growth could
occur when the slope of the
gradient falls below a critical level.
One way that the slope of
a gradient could be read by
individual cells is that they could
compare themselves with their
neighbors in terms of a parameter
whose absolute levels are
determined by the local
concentration of the morphogen
(e.g. a gene whose expression is
responsive to morphogen
concentrations). A role for Fat in
both PCP and growth regulation
could imply that Fat is an integral
component of a sharedmechanism
that enables cells to compare
themselves with their neighbors.Therefore linking Fat to the Hippo
pathway could potentially
represent an important advance in
understanding how long-range
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